Canada’s $7-Billion Pharmaceutical Exports to U.S. at Risk Amid Tariff Threat

Nearly $7 billion in Canadian pharmaceutical exports to the United States could soon be hit by new tariffs, as the White House launches an investigation into the entire pharmaceutical supply chain. The move places Canadian pharmaceutical products at risk of being included in a sweeping round of trade measures.

Pharmaceuticals, along with automobiles and electronics, are among the top U.S. imports now facing potential tariffs. US President Donald Trump recently signaled aggressive action, stating that tariffs on pharmaceuticals will reach levels "you've never seen before."

In addition to pharmaceuticals, the U.S. has also opened a separate investigation into its dependence on foreign semiconductor imports.

Meanwhile, Canadian researchers have warned that imposing tariffs could significantly disrupt pharmaceutical supply chains, potentially leading to widespread drug shortages in both countries.